Accelerating Therapeutic DiscoveryTM

News From The Alpha-1 Project

25 Latest Articles Current Articles | Archives | Search

Entries for April 2019

05

Arrowhead Pharmaceuticals Files IND for Pivotal Phase 2/3 Study ofARO-AAT for Treatment of Alpha-1 Liver Disease

Posted on April 05, 2019
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for an adaptive Phase 2/3 trial with t...

[Read More...]

The Alpha-1 Project Alpha-1 Antitrypsin Deficiency Therapeutic Strategies Clinical Trial Resources Progress Reports About Us Login
Copyright (c) 2021 The Alpha 1 Project All Rights Reserved | Terms Of Use | Privacy Statement
The Alpha-1 Project® is a registered trademark of the Alpha-1 Foundation, Inc.
Accelerating Therapeutic Discovery™ is a registered trademark of The Alpha-1 Foundation, Inc.
Website by IMI Software, Inc.